Our study proposes a specific transformation pattern of MDK, ranging from a precursor AK to primary cSCC and finally recurrent cSCC, providing a novel potential treatment target in cSCC (Figure 7B). This evidence concerns the gene MDK and skin squamous cell carcinoma.